FIL Ltd

CIK 318989 · last filed 2024-09-18

FIL Ltd is a corporate insider who has filed 13 SEC Form 4 insider transactions across 7 companies since 2012. The most recent filing, for BCAX, was dated Sep 18, 2024. Across all open-market trades the lifetime net is −$21.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $105.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$105.88M

Companies

7

Total Filings

13

Lifetime Open-Market Net

-$21.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCAX 1,013,853 $23.76 $24.09M $0 1 2024-09-18
GPCR 624,239 $52.13 $32.54M $0 1 2023-02-09
XLO 15,622 $9.18 $143.4K $0 1 2021-10-28
Surface Oncology, Inc. (SURF) Delisted 886,716 $1.07 $948.8K $0 1 2018-04-25
Cogent Biosciences, Inc. (UMRX) Delisted 1,110,932 $0 1 2018-04-05
DNLI 1,815,536 $24.69 $44.83M $0 1 2017-12-14
IRWD 10%+ Owner 995,804 $4.30 $4.28M -$21.20M 7 2013-03-25

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-09-18 BCAX Conv (C) +1,013,853 $0 EDGAR
2023-02-09 GPCR Conv (C) +6,473,761 $0 EDGAR
2021-10-28 XLO Conv (C) +218,705 $0 EDGAR
2018-04-25 Surface Oncology, Inc. (SURF) Delisted Conv (C) +886,716 $0 EDGAR
2018-04-05 Cogent Biosciences, Inc. (UMRX) Delisted Conv (C) +1,138,274 $0 EDGAR
2017-12-14 DNLI Conv (C) +3,273,807 $0 EDGAR
2013-03-25 IRWD Sell (S) −480,200 $0 EDGAR
2012-10-15 IRWD Sell (S) −425,750 -$5.64M EDGAR
2012-10-03 IRWD Sell (S) −16,800 -$218.5K EDGAR
2012-09-25 IRWD Sell (S) −471,372 -$6.82M EDGAR
Showing 110 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.